About
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, glycols and glycol ethers, fiber intermediates, and acetates and esters, as well as industrial alcohols, ketones, amines, oleochemicals, intermediates, olefins, phosphates, fertilizers, monomers, and chemicals. It serves pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap296 Cr
P/E70.90
Div Yield0.00 %
Book Value₹53.00
52w High₹100.00
52w Low₹50.30
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44.63 | 189.47 | 96.43 | 84.16 | 102.21 | 108.10 | 133.79 | 105.14 | 126.91 | 210.35 | 76.48 | 57.83 | 50.96 |
| Expenses | 43.31 | 185.13 | 97.94 | 81.52 | 100.50 | 112.31 | 131.59 | 101.42 | 125.73 | 211.79 | 73.78 | 55.99 | 49.62 |
| Operating Profit | 1.32 | 4.34 | -1.51 | 2.64 | 1.71 | -4.21 | 2.20 | 3.72 | 1.18 | -1.44 | 2.70 | 1.84 | 1.34 |
| OPM % | 2.96 | 2.29 | -1.57 | 3.14 | 1.67 | -3.89 | 1.64 | 3.54 | 0.93 | -0.68 | 3.53 | 3.18 | 2.63 |
| Other Income | 1.72 | -0.43 | 4.18 | 0.79 | 1.55 | 7.54 | 0.68 | 0.02 | 1.58 | 5.14 | 0.29 | 0.84 | 0.70 |
| Depreciation | 0.85 | 0.85 | 0.83 | 0.69 | 0.49 | 0.41 | 0.90 | 1.51 | 0.47 | 1.15 | 1.06 | 1.27 | 0.89 |
| Interest | 1.67 | 1.78 | 0.92 | 1.26 | 1.04 | 1.30 | 0.58 | 0.49 | 0.96 | 0.40 | 0.47 | 0.41 | 0.42 |
| Profit before tax | 0.52 | 1.28 | 0.92 | 1.48 | 1.73 | 1.62 | 1.40 | 1.74 | 1.33 | 2.15 | 1.46 | 1.00 | 0.73 |
| Tax % | -98.08 | -21.88 | 38.04 | 31.08 | 20.81 | 71.60 | 48.57 | 8.62 | 6.77 | -0.47 | 30.14 | -22.00 | 0.00 |
| Net Profit | 1.02 | 1.56 | 0.57 | 1.02 | 1.37 | 0.47 | 0.72 | 1.60 | 1.24 | 2.15 | 1.02 | 1.23 | 0.72 |
| EPS in Rs | 0.36 | 0.55 | 0.20 | 0.36 | 0.48 | 0.17 | 0.25 | 0.57 | 0.44 | 0.77 | 0.40 | 0.48 | 0.28 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 472.00 | 474.00 | 396.00 | 419.00 | 493.00 | 348.00 | 298.00 | 354.00 | 349.00 | 396.00 | 246.00 | 213.00 |
| Expenses | 465.00 | 471.00 | 391.00 | 411.00 | 481.00 | 344.00 | 294.00 | 347.00 | 342.00 | 386.00 | 245.00 | 212.00 |
| Operating Profit | 7.00 | 3.00 | 4.00 | 8.00 | 11.00 | 5.00 | 3.00 | 8.00 | 8.00 | 10.00 | 1.00 | 1.00 |
| OPM % | 1.50 | 0.60 | 1.10 | 1.80 | 2.30 | 1.30 | 1.10 | 2.20 | 2.20 | 2.40 | 0.40 | 0.60 |
| Other Income | 6.00 | 10.00 | 7.00 | 3.00 | 3.00 | 7.00 | 7.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Interest | 5.00 | 5.00 | 4.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 4.00 | 2.00 | 1.00 |
| Depreciation | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Profit before tax | 5.00 | 6.00 | 5.00 | 6.00 | 10.00 | 8.00 | 7.00 | 9.00 | 8.00 | 8.00 | 2.00 | 1.00 |
| Tax % | 27.00 | 34.00 | 12.00 | 37.00 | 35.00 | 21.00 | 20.00 | 27.00 | 25.00 | 31.00 | 29.00 | 23.00 |
| Net Profit | 4.00 | 4.00 | 5.00 | 4.00 | 7.00 | 7.00 | 6.00 | 7.00 | 6.00 | 5.00 | 1.00 | 1.00 |
| EPS in Rs | 1.40 | 1.42 | 1.67 | 1.49 | 2.58 | 2.78 | 2.48 | 2.80 | 2.64 | 3.02 | 0.77 | 0.65 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28.00 | 28.00 | 28.00 | 25.00 | 25.00 | 23.00 | 23.00 | 23.00 | 23.00 | 18.00 | 17.00 | 17.00 |
| Reserves | 122.00 | 110.00 | 105.00 | 92.00 | 88.00 | 75.00 | 69.00 | 63.00 | 57.00 | 31.00 | 20.00 | 19.00 |
| Borrowings | 50.00 | 35.00 | 31.00 | 38.00 | 14.00 | 18.00 | 18.00 | 16.00 | 3.00 | 10.00 | 15.00 | 11.00 |
| Other Liabilities | 97.00 | 117.00 | 139.00 | 136.00 | 117.00 | 116.00 | 84.00 | 43.00 | 86.00 | 83.00 | 74.00 | 69.00 |
| Total Liabilities | 297.00 | 291.00 | 303.00 | 291.00 | 245.00 | 233.00 | 194.00 | 146.00 | 170.00 | 142.00 | 125.00 | 115.00 |
| Fixed Assets | 26.00 | 16.00 | 13.00 | 14.00 | 14.00 | 14.00 | 12.00 | 12.00 | 12.00 | 12.00 | 8.00 | 6.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.00 | 2.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 269.00 | 272.00 | 289.00 | 277.00 | 230.00 | 218.00 | 181.00 | 133.00 | 157.00 | 130.00 | 117.00 | 109.00 |
| Total Assets | 297.00 | 291.00 | 303.00 | 291.00 | 245.00 | 233.00 | 194.00 | 146.00 | 170.00 | 142.00 | 125.00 | 115.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 10.00 | 10.00 | -3.00 | -1.00 | 0.00 | 5.00 | 3.00 | 1.00 | -20.00 | 1.00 | 6.00 | 3.00 |
| Cash from Investing Activity | -12.00 | -6.00 | -2.00 | 0.00 | -3.00 | -3.00 | -1.00 | -1.00 | -1.00 | -5.00 | -3.00 | -2.00 |
| Cash from Financing Activity | 2.00 | -4.00 | 6.00 | 1.00 | 2.00 | -2.00 | -2.00 | -2.00 | 23.00 | 4.00 | -2.00 | -2.00 |
| Net Cash Flow | 0.00 | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | -3.00 | 2.00 | -1.00 | 1.00 | -1.00 |
| Free Cash Flow | -2.00 | 5.00 | -4.00 | -2.00 | -2.00 | 3.00 | 2.00 | -1.00 | -21.00 | -4.00 | 3.00 | 1.00 |
| CFO/OP % | 164.00 | 421.00 | -37.00 | 13.00 | 36.00 | 154.00 | 135.00 | 37.00 | -232.00 | 28.00 | 560.00 | 239.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 100.00 | 103.00 | 170.00 | 165.00 | 101.00 | 170.00 | 118.00 | 109.00 | 100.00 | 75.00 | 108.00 | 114.00 |
| Inventory Days | 33.00 | 36.00 | 33.00 | 26.00 | 11.00 | 20.00 | 21.00 | 23.00 | 16.00 | 5.00 | 3.00 | 7.00 |
| Days Payable | 66.00 | 81.00 | 123.00 | 115.00 | 86.00 | 120.00 | 98.00 | 40.00 | 84.00 | 71.00 | 108.00 | 117.00 |
| Cash Conversion Cycle | 68.00 | 58.00 | 80.00 | 76.00 | 26.00 | 69.00 | 42.00 | 92.00 | 32.00 | 9.00 | 3.00 | 5.00 |
| Working Capital Days | 90.00 | 89.00 | 106.00 | 89.00 | 68.00 | 91.00 | 99.00 | 77.00 | 69.00 | 34.00 | 40.00 | 49.00 |
| ROCE % | 6.00 | 6.00 | 6.00 | 6.00 | 10.00 | 9.00 | 8.00 | 12.00 | 14.00 | 22.00 | 7.00 | 7.00 |
Corporate Actions
7 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Other | 23 Sep 2024 | — | — | — | Annual General Meeting |
| Other | 29 Aug 2023 | — | — | — | Annual General Meeting |
| Other | 22 Sep 2022 | — | — | — | Annual General Meeting |
| Other | 02 Sep 2021 | — | — | — | Annual General Meeting |
| Dividend | 13 Dec 2018 | 14 Dec 2018 | — | 0.10 | |
| Bonus | 25 Jun 2012 | 26 Jun 2012 | 1:5 | — | |
| Other | 19 Jan 2012 | 20 Jan 2012 | — | — | Right Issue of Equity Shares |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update27 May from smera
-
Rating update26 Aug 2025 from icra
-
Rating update4 Mar 2025 from smera
-
Rating update29 May 2024 from icra
-
Rating update23 Feb 2024 from smera
-
Rating update21 Nov 2023 from smera